home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

23.02 -0.46 (-1.96%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

49 50 Next >

Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday ↗

October 07, 2024

Via Benzinga

Hims & Hers Health Stock Is Rising Monday: What's Going On? ↗

October 07, 2024

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this week.

Via Benzinga

Topics Stocks

Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages ↗

October 04, 2024

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's Q3 2024 revenue is expected to exceed projections as concerns rise over...

Via Benzinga

Massive News for Hims & Hers Stock: The Truth About Today's Move ↗

October 04, 2024

Hims & Hers may not be hurt by GLP-1 news the way investors think.

Via The Motley Fool

How Is The Market Feeling About Hims & Hers Health? ↗

September 17, 2024

Via Benzinga

Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (8 Ratings) ↗

September 13, 2024

Via Benzinga

Is Hims & Hers Health Stock a Buy? ↗

September 10, 2024

The risk-reward proposition is pretty one-sided here.

Via The Motley Fool

2 Winning Growth Stocks That Are Screaming Buys Right Now ↗

October 04, 2024

These top stocks are on a winning streak and have the businesses to keep it going.

Via The Motley Fool

AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday ↗

October 03, 2024

Via Benzinga

Hims & Hers Health Stock Is Tumbling Thursday: Here's Why ↗

October 03, 2024

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli Lilly And Co's (NYSE:LLY) weight-loss and diabetes drugs from its shortage...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 03, 2024

Via Benzinga

These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer ↗

October 02, 2024

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

Via The Motley Fool

Is Hims & Hers Health Stock a Buy? ↗

August 29, 2024

The stock has been a strong performer this year, but the best could be yet to come.

Via The Motley Fool

Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel ↗

September 19, 2024

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military personnel, veterans, teachers, nurses, and first responders. The telehealth...

Via Benzinga

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

September 18, 2024

From Hims & Hers

Via Business Wire

Hims & Hers Acquisition: How Innovation Will Flourish ↗

September 18, 2024

Buying a new pharmacy will allow Hims & Hers to expand into new markets.

Via The Motley Fool

1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) ↗

September 17, 2024

Telemedicine once seemed like it was going to revolutionize healthcare.

Via The Motley Fool

Hims & Hers Stock Pops After Massive Acquisition ↗

September 13, 2024

The healthcare company will be making more of the product it sells.

Via The Motley Fool

Hims & Hers Health Stock Is Crashing: Should You Buy the Dip? ↗

September 11, 2024

Shares of Hims & Hers are falling even as the company has been posting some solid results.

Via The Motley Fool

Is Hims & Hers Health the Next Teladoc? ↗

September 11, 2024

Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.

Via The Motley Fool

Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval ↗

September 11, 2024

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The company-funded study revealed a 7.4% reduction in body-mass index for children...

Via Benzinga

Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long

September 10, 2024

Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't last

Via MarketBeat

Topics Economy

Four Stocks To Watch This Week - Monday, Sept 9 ↗

September 09, 2024

Inconsistent patchy behavior looks most likely in the very short term, but stocks still have decent potential in the medium term. Stay focused and be patient for the optimal setups near Key Levels.

Via Talk Markets

Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation ↗

September 05, 2024

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing sustainability challenges.

Via Benzinga

Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know. ↗

September 05, 2024

Lilly just lowered the price of Zepbound.

Via The Motley Fool

Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever ↗

September 05, 2024

There is something for everybody in America's $4.5 trillion healthcare market.

Via The Motley Fool

Billionaires Are Buying Hims & Hers Health Hand Over Fist. Should You Follow Their Lead? ↗

September 01, 2024

Sales growth could accelerate now that it provides lower-cost, weight-management drugs.

Via The Motley Fool

2 No-Brainer Growth Stocks to Buy With $200 Right Now ↗

August 31, 2024

These businesses are rapidly growing profits and cash flows.

Via The Motley Fool

Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review ↗

August 30, 2024

The Dow Jones hit a new high while Nvidia led a Nasdaq retreat.

Via Investor's Business Daily

Topics Stocks

Why Hims & Hers Health Stock Was Falling This Week ↗

August 29, 2024

A new threat from Eli Lilly pushed the stock lower.

Via The Motley Fool

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com